Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Renal extraction of angiotensin II.

Jackson EK, Herzer WA.

J Pharmacol Exp Ther. 2003 Dec;307(3):1001-6. Epub 2003 Oct 8.

PMID:
14534364
2.

Type IV phosphodiesterase inhibition improves cardiac contractility in endotoxemic rats.

Thomas NJ, Carcillo JA, Herzer WA, Mi Z, Tofovic SP, Jackson EK.

Eur J Pharmacol. 2003 Mar 28;465(1-2):133-9.

PMID:
12650842
3.

A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemide.

Jackson EK, Kost CK Jr, Herzer WA, Smits GJ, Tofovic SP.

J Pharmacol Exp Ther. 2001 Dec;299(3):978-87.

PMID:
11714886
4.

Enhanced interaction between renovascular alpha(2)-adrenoceptors and angiotensin II receptors in genetic hypertension.

Jackson EK, Herzer WA, Kost CK Jr, Vyas SJ.

Hypertension. 2001 Sep;38(3):353-60.

PMID:
11566904
5.

Regional vascular selectivity of angiotensin II.

Jackson EK, Herzer WA.

J Pharmacol Exp Ther. 2001 May;297(2):736-45.

PMID:
11303065
7.

Local and systemic effects of peritoneal lavage with high concentrations of adenosine in rats.

Jackson EK, Swamy RS, Herzer WA, Mi Z.

Aliment Pharmacol Ther. 2000 Oct;14(10):1371-80.

8.

Persistent improvement of cardiovascular risk factors in spontaneously hypertensive rats following early short-term captopril treatment.

Kost CK Jr, Rominski BR, Herzer WA, Jackson EK, Tofovic SP.

Clin Exp Hypertens. 2000 Feb;22(2):127-43.

PMID:
10744354
9.

Effect of cardiac receptor stimulation on renal vascular resistance in the pregnant rat.

Hines T, Herzer WA.

Am J Physiol Regul Integr Comp Physiol. 2000 Jan;278(1):R171-8.

10.

Diuretic response to adenosine A(1) receptor blockade in normotensive and spontaneously hypertensive rats: role of pertussis toxin-sensitive G-proteins.

Kost CK Jr, Herzer WA, Rominski BR, Mi Z, Jackson EK.

J Pharmacol Exp Ther. 2000 Feb;292(2):752-60.

PMID:
10640315
11.

A comparison of the natriuretic/diuretic effects of rat vs. human leptin in the rat.

Jackson EK, Herzer WA.

Am J Physiol. 1999 Nov;277(5):F761-5. doi: 10.1152/ajprenal.1999.277.5.F761.

PMID:
10564240
12.

Angiotensin II-induced renal vasoconstriction in genetic hypertension.

Jackson EK, Herzer WA, Vyas SJ, Kost CK Jr.

J Pharmacol Exp Ther. 1999 Oct;291(1):329-34.

PMID:
10490921
14.

Pertussis toxin-sensitive G-proteins and regulation of blood pressure in the spontaneously hypertensive rat.

Kost CK Jr, Herzer WA, Li PJ, Jackson EK.

Clin Exp Pharmacol Physiol. 1999 May-Jun;26(5-6):449-55.

PMID:
10386237
15.

Effects of type IV phosphodiesterase inhibition on cardiac function in the presence and absence of catecholamines.

Herzer WA, Thomas NJ, Carcillo JA, Tofovic SP, Jackson EK.

J Cardiovasc Pharmacol. 1998 Nov;32(5):769-76.

PMID:
9821851
16.
17.

Injured erythrocytes release adenosine deaminase into the circulation.

Jackson EK, Mi Z, Koehler MT, Carcillo JA Jr, Herzer WA.

J Pharmacol Exp Ther. 1996 Dec;279(3):1250-60.

PMID:
8968348
18.

Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrine.

Carcillo JA, Herzer WA, Mi Z, Thomas NJ, Jackson EK.

J Pharmacol Exp Ther. 1996 Dec;279(3):1197-204.

PMID:
8968341
19.

Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure.

Begany DP, Carcillo JA, Herzer WA, Mi Z, Jackson EK.

J Pharmacol Exp Ther. 1996 Jul;278(1):37-41.

PMID:
8764333
20.

Angiotensin II-induced structural and functional alterations in spontaneously hypertensive rat kidney.

Kost CK Jr, Herzer WA, Li P, Notoya M, Mizuhira V, Inagami T, Jackson EK.

Am J Physiol. 1996 Jan;270(1 Pt 2):F229-36.

PMID:
8769844
21.

Role of adenosine in noradrenergic neurotransmission during hemorrhagic hypotension.

Jackson EK, Herzer WA, Kuan CJ.

J Pharmacol Exp Ther. 1994 Aug;270(2):589-94.

PMID:
8071851
22.

Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.

Kost CK Jr, Herzer WA, Li P, Jackson EK.

J Pharmacol Exp Ther. 1994 Apr;269(1):82-8.

PMID:
8169855
23.

Defective modulation of angiotensin II-induced renal vasoconstriction in hypertensive rats.

Jackson EK, Herzer WA.

Hypertension. 1994 Mar;23(3):329-36.

PMID:
8125559
24.

3-isobutyl-1-methylxanthine decreases renal cortical interstitial levels of adenosine and inosine.

Mi Z, Herzer WA, Zhang Y, Jackson EK.

Life Sci. 1994;54(16):277-82.

PMID:
7512185
25.

KF17837 is an A2 adenosine receptor antagonist in vivo.

Jackson EK, Herzer WA, Suzuki F.

J Pharmacol Exp Ther. 1993 Dec;267(3):1304-10.

PMID:
8263794
26.

Angiotensin II/prostaglandin I2 interactions in spontaneously hypertensive rats.

Jackson EK, Herzer WA.

Hypertension. 1993 Nov;22(5):688-98.

PMID:
8225529
27.

Cardiovascular and renal effects of blocking A1 adenosine receptors.

Kuan CJ, Herzer WA, Jackson EK.

J Cardiovasc Pharmacol. 1993 May;21(5):822-8.

PMID:
7685455
28.

An experimental paradigm for investigating the role of endogenous adenosine/A1 receptor interactions in vivo.

Kuan CJ, Herzer WA, Jackson EK.

J Pharmacol Exp Ther. 1992 Nov;263(2):657-62.

PMID:
1432696
29.

Interaction between angiotensin II and adenosine in mediating the vasoconstrictor response to intrarenal hypertonic saline infusions in the dog.

Deray G, Sabra R, Herzer WA, Jackson EK, Branch RA.

J Pharmacol Exp Ther. 1990 Feb;252(2):631-5.

PMID:
2179530
30.
31.

Effects of thromboxane synthase inhibitors on renal function.

Jackson EK, Goto F, Uderman HD, Workman RJ, Herzer WA, FitzGerald GA, Branch RA.

Naunyn Schmiedebergs Arch Pharmacol. 1988 Feb;337(2):183-90.

PMID:
3285227
32.

Effects of atrial natriuretic factor on hormone-induced renin release.

Deray G, Branch RA, Herzer WA, Ohnishi A, Jackson EK.

Hypertension. 1987 May;9(5):513-7.

PMID:
2952592
33.

Adenosine inhibits beta-adrenoceptor but not DBcAMP-induced renin release.

Deray G, Branch RA, Herzer WA, Ohnishi A, Jackson EK.

Am J Physiol. 1987 Jan;252(1 Pt 2):F46-52.

PMID:
3028156
34.

Effects of atrial natriuretic factor on noradrenergic neurotransmission in vivo in the rat mesentery.

Herzer WA, Deray G, Jackson EK.

J Cardiovasc Pharmacol. 1987 Jan;9(1):125-8.

PMID:
2434788
35.

Dyke Award. Evaluation of contrast-enhanced MR imaging in a brain-abscess model.

Runge VM, Clanton JA, Price AC, Herzer WA, Allen JH, Partain CL, James AE Jr.

AJNR Am J Neuroradiol. 1985 Mar-Apr;6(2):139-47.

PMID:
3920873
36.

The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption.

Runge VM, Clanton JA, Price AC, Wehr CJ, Herzer WA, Partain CL, James AE Jr.

Magn Reson Imaging. 1985;3(1):43-55.

PMID:
3923292
37.

Intravascular contrast agents suitable for magnetic resonance imaging.

Runge VM, Clanton JA, Herzer WA, Gibbs SJ, Price AC, Partain CL, James AE Jr.

Radiology. 1984 Oct;153(1):171-6.

PMID:
6433402
38.

Attenuation of noradrenergic neurotransmission by the thromboxane synthetase inhibitor, UK 38,485.

Jackson EK, Uderman HD, Herzer WA, Branch RA.

Life Sci. 1984 Jul 9;35(2):221-8.

PMID:
6330486
39.

Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt University.

Runge VM, Clanton JA, Price AC, Herzer WA, Wehr CJ, Lukehart CM, Partain CL, James AE Jr.

Physiol Chem Phys Med NMR. 1984;16(2):113-22.

PMID:
6438656
40.

Effects of indomethacin on beta adrenoreceptor-stimulated renin release in the dog.

Jackson EK, Herzer WA, Zimmerman JB, Oates JA, Branch RA, Gerkens JF.

J Pharmacol Exp Ther. 1982 Aug;222(2):414-8.

PMID:
6284909
41.

6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.

Jackson EK, Herzer WA, Zimmerman JB, Branch RA, Oates JA, Gerkens JF.

J Pharmacol Exp Ther. 1981 Jan;216(1):24-7.

PMID:
7005428

Supplemental Content

Loading ...
Support Center